Ha In-Hyuk, Kim Eun-San, Lee Sook-Hyun, Lee Yoon Jae, Song Hyun Jin, Kim Younhee, Kim Koh-Woon, Cho Jae-Heung, Lee Jun-Hwan, Shin Byung-Cheul, Lee Jinho, Shin Joon-Shik
Jaseng Spine and Joint Research Institute, Jaseng Medical Foundation, Seoul, South Korea.
College of Pharmacy, University of Florida, Gainesville, FL, United States.
Front Med (Lausanne). 2022 May 11;9:896422. doi: 10.3389/fmed.2022.896422. eCollection 2022.
This study aimed to compare the cost-effectiveness of manual therapy and usual care for patients with chronic neck pain. A cost-utility analysis alongside a pragmatic randomized controlled trial was conducted in five South Korean hospitals. Data were procured from surveys and nationally representative data. Participants were 108 patients aged between 19 and 60 years, with chronic neck pain persisting for at least 3 months and a pain intensity score of ≥5 on the numerical rating scale in the last 3 days. The study was conducted for 1 year, including 5 weeks of intervention and additional observational periods. Participants were divided into a manual therapy (Chuna) group and a usual care group, and quality-adjusted life-years, costs, and the incremental cost-effectiveness ratio were calculated. The quality-adjusted life-years of the manual therapy group were 0.024 higher than that of the usual care group. From the societal perspective, manual therapy incurred a lower cost-at $2,131-and was, therefore, the more cost-effective intervention. From a healthcare system perspective, the cost of manual therapy was higher, with an incremental cost-effectiveness ratio amount of $11,217. Manual therapy is more cost-effective for non-specific chronic neck pain management from both a healthcare system and societal perspective.
本研究旨在比较手法治疗与常规护理对慢性颈痛患者的成本效益。在韩国的五家医院进行了一项成本效用分析以及一项实用随机对照试验。数据来自调查和具有全国代表性的数据。参与者为108名年龄在19至60岁之间的患者,患有持续至少3个月的慢性颈痛,且在过去3天内数字评分量表上的疼痛强度得分≥5。该研究进行了1年,包括5周的干预期和额外的观察期。参与者被分为手法治疗(推拿)组和常规护理组,并计算了质量调整生命年、成本和增量成本效益比。手法治疗组的质量调整生命年比常规护理组高0.024。从社会角度来看,手法治疗的成本较低,为2131美元,因此是更具成本效益的干预措施。从医疗系统角度来看,手法治疗的成本较高,增量成本效益比为11217美元。从医疗系统和社会角度来看,手法治疗在非特异性慢性颈痛管理方面更具成本效益。